老年痴呆症，又名阿尔茨海默病，是以这种病症的发现者爱罗斯·阿兹·海默医生的名字命名。这是一种缓慢破坏记忆力和思维能力大脑疾病，不可逆转且是递增的。
Alzheimer's disease, named after Dr. Alois Alzheimer, is a brain disease that slowly destroys memory and thinking capability.
根据阿尔茨海默病研究中心的报告，在美国有超过5百万人患有老年痴呆症，到2050年这一人数将会翻两番。
More than 5 million people in the U.S. have Alzheimer's disease, and this number will quadruple by 2050, according to the Alzheimer's Association.
根据阿尔茨海默病研究中心的报告，在美国有超过5百万人患有老年痴呆症，到2050年这一人数将会翻两番。
More than 5 million people in the U. S. have Alzheimer's disease, and this number will quadruple by 2050, according to the Alzheimer's Association.
据阿尔茨海默研究中心报告，在美国，有超过5百万人患有阿尔茨海默病，即老年痴呆症。
More than 5 million people in the U.S. have Alzheimer's disease according to the Alzheimer's Association.
阿尔茨海默氏病(老年痴呆症)以记忆逐渐衰退和严重的认知损害为特征。
Alzheimer's disease (AD) is characterised by progressive memory loss and severe cognitive impairment.
最常见的痴呆症是阿尔茨海默氏症，也就是老年痴呆症。目前确切诊断这种病的唯一方法是脑部解剖。
The most common form of dementia is Alzheimer's Disease, and currently, it can only be definitively diagnosed in an autopsy, by examining the brain.
用途：第二代中枢性乙酰胆碱酯酶抑制剂，是一只具有高度选择性、可逆性治疗阿尔茨海默病（老年痴呆）的药物。
Usage: The second generation of central acetylcholinesterase inhibitor, used as a highly selective and reversible treatment of Alzheimer's disease.
用途：第二代中枢性乙酰胆碱酯酶抑制剂，是一只具有高度选择性、可逆性治疗阿尔茨海默病（老年痴呆）的药物。
Usage: The second generation of central acetylcholinesterase inhibitor, used as a highly selective and reversible treatment of Alzheimer's disease.
应用推荐